Confirmation of administrative claims-identified opportunistic infections and other serious potential adverse events associated with tumor necrosis factor α antagonists and disease-modifying antirheumatic drugs
about
The Value of Patient-Centred Registries in Phase IV Drug SurveillanceUnderstanding the burden of tuberculosis among American Indians/Alaska Natives in the U.S.: a validation studySystematic review of validation studies of the use of administrative data to identify serious infections.Risk of hospitalised infection in rheumatoid arthritis patients receiving biologics following a previous infection while on treatment with anti-TNF therapy.Risk of hospitalized bacterial infections associated with biologic treatment among US veterans with rheumatoid arthritis.Validity of physician-reported hospitalized infections in a US arthritis registry.Comparative Risk of Hospitalized Infection Associated With Biologic Agents in Rheumatoid Arthritis Patients Enrolled in Medicare.Adverse events associated with common therapy regimens for moderate-to-severe Crohn's disease.Fine-needle aspiration of histoplasmosis in the era of endoscopic ultrasound and endobronchial ultrasound: cytomorphologic features and correlation with clinical laboratory testing.
P2860
Q29395899-F1BF0744-D5AA-4BDC-97BF-DB5A107A2A1FQ33681111-A1B7BD70-D821-49F6-BA73-E8CBDD16F68FQ34555474-9E37C3F8-DBE7-4054-B6F8-1B9AD51E273EQ35636624-42958712-5B43-4195-8C42-F6F44BBBEC9BQ37330765-B1A91A61-6ADD-40BC-9BB3-6C8301EA6A02Q37347648-19BD62B7-6E51-4617-80DB-6D04668FF2A2Q40598586-98C5A7FC-A0F7-4CF7-AFD7-0D387DEA3BABQ45966647-A019E8C1-73B6-4C0D-873D-C9C296B9BB38Q46055787-1D0A43AD-3623-4264-9B3B-F55723F34F4A
P2860
Confirmation of administrative claims-identified opportunistic infections and other serious potential adverse events associated with tumor necrosis factor α antagonists and disease-modifying antirheumatic drugs
description
scientific article published on 01 March 2007
@en
wetenschappelijk artikel
@nl
наукова стаття, опублікована у 2007
@uk
name
Confirmation of administrative ...... -modifying antirheumatic drugs
@en
Confirmation of administrative ...... -modifying antirheumatic drugs
@nl
type
label
Confirmation of administrative ...... -modifying antirheumatic drugs
@en
Confirmation of administrative ...... -modifying antirheumatic drugs
@nl
prefLabel
Confirmation of administrative ...... -modifying antirheumatic drugs
@en
Confirmation of administrative ...... -modifying antirheumatic drugs
@nl
P2093
P356
P1476
Confirmation of administrative ...... -modifying antirheumatic drugs
@en
P2093
P304
P356
10.1002/ART.22544
P577
2007-03-01T00:00:00Z